Published Date : 05 Nov 19 | Views: 158 | Industry : Life Science
Triamcinolone Acetonide Cream Finds Use in Treatment
of Seborrheic Dermatitis
The global
triamcinolone market is segmented into inhalation, injection, cream, and others
on the basis of product type. Based on distribution channel, the global
triamcinolone market is segmented into drug stores, hospitals, and others.
Triamcinolone acetonide cream is used to treat itching of the genital area, seborrheic
dermatitis, and atopic dermatitis. Triamcinolone injection is used in the
treatment of gout and certain types of arthritis. Triamcinolone inhalation could
be used to prevent asthma attacks. However, it may not find application in the
treatment of asthma attacks that have already begun.
Demand for
triamcinolone could be high in developing countries because of increased
prevalence of skin diseases. The report offers exhaustive analysis of key
regional markets for triamcinolone, viz. Asia Pacific, North America, Europe,
the MEA, and South America. Each region is thoroughly researched about and
analyzed on the basis of different parameters such as market share, growth
potential, recent developments, and growth rate. The geographical analysis of
the global triamcinolone market provided in the report will help players to strategize
for their growth in individual regional markets.
Manufacturers Likely to Continue to Make Research and
Development Investments
The report
offers deep company profiling of popular players of the global triamcinolone
market such as Sanofi, Huapont, Bristol-Myers Squibb, Alkem Laboratories, J&J,
Teijin Pharma, Mylan, Glenmark, GSK, Sun Pharmaceutical, Cadila, Teligent, Abbott,
China Resources Sanjiu, and Novartis. Triamcinolone manufacturers are
anticipated to focus on launching new products to improve their portfolio. Players
may also continue to invest in research and development to explore new
applications of triamcinolone and offer more advanced products.
Use of Potential Substitutes Expected to Reduce Demand
for Triamcinolone
There are some
side effects associated with the use of triamcinolone, viz. irritation,
dryness, blistering, and allergic reaction. Availability of potential substitutes
could also hamper the demand in the global triamcinolone market. For instance, a
research study shows that procaine hydrochloride injection could be as
effective as triamcinolone acetonide in the management of carpal tunnel
syndrome.
Nonetheless, the global demand for triamcinolone could slightly improve because of its application in the treatment of common problems, including swelling, itching, and redness, caused due to eczema, psoriasis, and other skin conditions. Availability of triamcinolone in different forms such as inhaler, injection, and cream could help with its easy use in suitable applications. Triamcinolone could be used in the form of a dental paste to reduce pain, itching, and swelling occurring with mouth sores.
For more
information, please click: https://www.qyrconsulting.com/reports/triamcinolone-market